A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial

BACKGROUND: The cost-effectiveness of varenicline has been demonstrated in the US health care setting using the Benefits of Smoking Cessation on Outcomes (BENESCO) model to simulate the lifetime direct costs and consequences of a hypothetical cohort of US adult smokers who make a single attempt to q...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Christine L, Pietri, Guilhem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783141/
https://www.ncbi.nlm.nih.gov/pubmed/29403297
http://dx.doi.org/10.2147/CEOR.S153897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783141/
https://www.ncbi.nlm.nih.gov/pubmed/29403297
http://dx.doi.org/10.2147/CEOR.S153897

Ejemplares similares